methyl 5-aminolevulinate has been researched along with Cancer of the Vulva in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barlier, C; Bezdetnaya, L; Dolivet, G; Francois, A; Leufflen, L; Marchal, F; Salleron, J | 1 |
Beneton, N; Hainaut, E; Martin, L; Misery, L; Quereux, G; Rioli, DI; Samimi, M | 1 |
Carpentier, O; Lecomte, F; Mordon, SR; Mortier, L; Thecua, E; Vicentini, C | 1 |
Ballester, I; Belinchón, I; Cuesta, L; Guijarro, J; Oltra, F; Toledo, F | 1 |
4 other study(ies) available for methyl 5-aminolevulinate and Cancer of the Vulva
Article | Year |
---|---|
Photodynamic diagnosis with methyl-5-aminolevulinate in squamous intraepithelial lesions of the vulva: Experimental research.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Animals; Cell Line; Computer Systems; Female; Heterografts; Humans; Mice; Protoporphyrins; Spectrometry, Fluorescence; Squamous Intraepithelial Lesions of the Cervix; Tissue Distribution; Vulvar Neoplasms | 2018 |
Efficacy and tolerance of photodynamic therapy for vulvar Paget's disease: a multicentric retrospective study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Pain; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms | 2018 |
Treatment of a vulvar Paget's disease by photodynamic therapy with a new light emitting fabric based device.
Topics: Aminolevulinic Acid; Female; Humans; Middle Aged; Paget Disease, Extramammary; Photochemotherapy; Photosensitizing Agents; Vulvar Neoplasms | 2017 |
Photodynamic therapy of vulvar intraepithelial neoplasia using methyl aminolevulinate.
Topics: Adult; Aminolevulinic Acid; Carcinoma in Situ; Female; Humans; Photochemotherapy; Photosensitizing Agents; Vulvar Neoplasms | 2012 |